PATTERNS OF UTERINE ACTIVITY AFTER INTRAVAGINAL PROSTAGLANDIN-E2 DURING PREINDUCTION CERVICAL RIPENING

被引:44
|
作者
MILLER, AM [1 ]
RAYBURN, WF [1 ]
SMITH, CV [1 ]
机构
[1] UNIV NEBRASKA,MED CTR,COLL MED,DEPT OBSTET & GYNECOL,DIV MATERNAL FETAL MED,OMAHA,NE 68105
关键词
UTERINE ACTIVITY; PROSTAGLANDIN E2; CERVICAL RIPENING;
D O I
10.1016/0002-9378(91)90459-5
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
In a randomized study, uterine activity patterns were characterized with a portable pressure-sensitive device in 40 nonlaboring women at term with an unfavorable cervix who were undergoing preinduction cervical ripening with prostaglandin E2. The prostaglandin E2 was inserted into the posterior vaginal fornix as a single dose of either a 2.5 mg methylcellulose gel (20 cases) or 10 mg controlled-release pessary (20 cases). Uterine activity monitoring began 1 hour before dosing and continued for 12 hours. For those treated with the gel, low-amplitude, high-frequency contractions began within the first hour, reached a peak within 4 hours, and initiated sustained high-amplitude contractions in 10 (50%) cases. With the controlled-release pessary, low-amplitude, high-frequency contractions had a slightly later onset, reached a peak between the fifth and eight hours, and initiated sustained high-amplitude contractions in 18 (80%) cases. Uterine hyperstimulation occurred in two (10%) pessary cases, with no adverse effect after removal. We conclude that low-amplitude, high-frequency uterine contractions began with either method of intravaginal prostaglandin E2 delivery but led to sustained, high-amplitude contractions primarily with the pessary.
引用
收藏
页码:1006 / 1009
页数:4
相关论文
共 50 条
  • [1] PREINDUCTION CERVICAL RIPENING WITH PROSTAGLANDIN-E2 GEL - INTRACERVICAL VERSUS INTRAVAGINAL ROUTE
    ZANINI, A
    GHIDINI, A
    NORCHI, S
    BERETTA, E
    CORTINOVIS, I
    BOTTINO, S
    OBSTETRICS AND GYNECOLOGY, 1990, 76 (04): : 681 - 683
  • [2] CERVICAL RIPENING WITH INTRAVAGINAL PROSTAGLANDIN-E2 GEL
    PRINS, RP
    BOLTON, RN
    MARK, C
    NEILSON, DR
    WATSON, P
    OBSTETRICS AND GYNECOLOGY, 1983, 61 (04): : 459 - 462
  • [3] PREINDUCTION CERVICAL RIPENING WITH PROSTAGLANDIN-E2 INTRACERVICAL GEL
    LAUBE, DW
    ZLATNIK, FJ
    PITKIN, RM
    OBSTETRICS AND GYNECOLOGY, 1986, 68 (01): : 54 - 57
  • [4] PREINDUCTION CERVICAL RIPENING WITH PROSTAGLANDIN-E2 (PREPIDIL) GEL
    TROFATTER, KF
    BOWERS, D
    GALL, SA
    KILLAM, AP
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1985, 153 (03) : 268 - 271
  • [5] CERVICAL RIPENING WITH INTRAVAGINAL PROSTAGLANDIN-E2 GEL
    MACKENZIE, IZ
    EMBREY, MP
    BRITISH MEDICAL JOURNAL, 1977, 2 (6099): : 1381 - 1384
  • [6] CERVICAL RIPENING WITH INTRAVAGINAL PROSTAGLANDIN-E2 GEL
    CURET, LB
    GAUGER, LJ
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 1989, 28 (03) : 221 - 228
  • [7] DOUBLE-BLIND COMPARISON OF INTRAVAGINAL PROSTAGLANDIN-E2 GEL AND CHIP FOR PREINDUCTION CERVICAL RIPENING
    SMITH, CV
    RAYBURN, WF
    CONNOR, RE
    FREDSTROM, GR
    PHILLIPS, CB
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1990, 163 (03) : 845 - 847
  • [8] UTERINE AND FETAL DOPPLER FLOW CHANGES AFTER INTRAVAGINAL PROSTAGLANDIN-E2 THERAPY FOR CERVICAL RIPENING
    RAYBURN, WF
    ANDERSON, JC
    SMITH, CV
    APPEL, LL
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1991, 165 (01) : 125 - 126
  • [9] PREINDUCTION CERVICAL RIPENING WITH SEQUENTIAL USE OF PROSTAGLANDIN-E2 GEL
    PRINS, RP
    NEILSON, DR
    BOLTON, RN
    MARK, C
    WATSON, P
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1986, 154 (06) : 1275 - 1279
  • [10] PREINDUCTION CERVICAL RIPENING WITH INTRAVENOUS PROSTAGLANDIN-E2 (PGE2)
    KUMAR, J
    KARIM, SMM
    RATNAM, SS
    SINGAPORE JOURNAL OF OBSTETRICS & GYNAECOLOGY, 1986, 17 (02) : 103 - 108